Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Adventist Health System Deploys Glytec’s eGlycemic Management System®

Posted on: 01 Nov 18

Adventist Health System (AHS), one of the largest faith-based health systems in the U.S., has successfully deployed the eGlycemic Management System® from Glytec. As a result, 33 AHS acute care facilities across seven states are now utilizing Glytec’s solution for intravenous insulin optimization.

This press release features multimedia. View the full release here:

Adventist Health System has successfully deployed Glytec's eGlycemic Management System® at 33 acute care facilities across seven states. The diabetes therapy management solution includes single sign-on integration with the Cerner EMR and interfaces with lab, ADT and charting systems. (Graphic: Business Wire)

“We strive to deliver the best care possible, and this implementation is one way we are using technology to achieve that goal,” said Jackie Willis, MS, RN, vice president and chief clinical information officer for Adventist Information Technology. “Glytec is a leader in this space, and their solution allows us to enhance care for patients with diabetes and many others in need of intravenous insulin therapy.”

Implementation of the solution, which helps address the unique challenges of caring for patients with diabetes, includes single sign-on integration with the Cerner electronic medical record system and interfaces with lab, ADT and charting systems.

“With nearly a third of hospitalized patients requiring insulin therapy during their stay, it is critical to focus significant attention on this very important aspect of care,” said J. Michael Yurso, MD, FACS, vice president of clinical reliability for Adventist Health System. “As we continue to leverage best practices and innovation through our partnership with Glytec, we will increasingly improve care quality and outcomes, especially for the many patients with diabetes.”

About Glytec

Glytec is the pioneer of personalized digital therapeutics, enabling best practices for inpatient and outpatient insulin optimization. The company’s patented and FDA-cleared software-as-a-medical-device solutions improve the safety and health of people with diabetes and make insulin a more effective medication option for the millions unable to achieve their treatment goals. Glytec combines evidence-based decision support technologies with expert clinical services to optimize insulin therapies in the hospital and at home, leading to reductions in hypoglycemia and other complications as well as avoidable ED visits, hospitalizations, readmissions and drug waste. The company has offices in Waltham, Massachusetts and Greenville, South Carolina. For more information visit

About Adventist Health System (Soon to be AdventHealth)

With a sacred mission of Extending the Healing Ministry of Christ, Adventist Health System is a connected system of care for every stage of life and health. More than 80,000 skilled and compassionate caregivers in physician practices, hospitals, outpatient clinics, skilled nursing facilities, home health agencies and hospice centers provide individualized, wholistic care. A Christian mission, shared vision, common values, focus on whole-person health and commitment to making communities healthier unify the system's nearly 50 hospital campuses and hundreds of care sites in diverse markets throughout almost a dozen states. On Jan. 2, 2019, all of the system’s wholly owned locations will adopt the system name AdventHealth. For more information about Adventist Health System, visit

View source version on

Business Wire

Last updated on: 01/11/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.